SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-081730
Filing Date
2023-07-17
Accepted
2023-07-17 20:00:49
Documents
1
Period of Report
2023-07-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2321456-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2321456-7_4seq1.xml 4 7553
  Complete submission text file 0001104659-23-081730.txt   9130
Mailing Address 7 BRYANT PARK 23RD FLOOR NEW YORK CITY NY 10018
Business Address 650-475-3734
Shah Nimish P (Reporting) CIK: 0001698082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41740 | Film No.: 231092704

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Issuer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)